Literature DB >> 7870586

Low stringency-PCR (LS-PCR) allows entirely internally standardized DNA quantitation.

O L Caballero1, L L Villa, A J Simpson.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7870586      PMCID： PMC306649          DOI： 10.1093/nar/23.1.192

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN： 0305-1048            Impact factor:   16.971


× No keyword cloud information.
  12 in total

1.  Competitive PCR.

Authors:  P D Siebert; J W Larrick
Journal:  Nature       Date:  1992-10-08       Impact factor: 49.962

2.  Sex determination by low stringency PCR (LS-PCR).

Authors:  E Dias Neto; F R Santos; S D Pena; A J Simpson
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

3.  Absolute quantification of target DNA: a simple competitive PCR for efficient analysis of multiple samples.

Authors:  V Zachar; R A Thomas; A S Goustin
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

4.  Rapid silver staining and recovery of PCR products separated on polyacrylamide gels.

Authors:  C J Sanguinetti; E Dias Neto; A J Simpson
Journal:  Biotechniques       Date:  1994-11       Impact factor: 1.993

5.  Low-stringency PCR provides an internal control for negative results in PCR-based diagnosis.

Authors:  O L de Caballero; E Dias Neto; M C Koury; A J Romanha; A J Simpson
Journal:  PCR Methods Appl       Date:  1994-04

6.  Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by a PCR aided transcript titration assay (PATTY).

Authors:  M Becker-André; K Hahlbrock
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

7.  Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction.

Authors:  G Gilliland; S Perrin; K Blanchard; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

Review 8.  Human papillomaviruses in the pathogenesis of anogenital cancer.

Authors:  H zur Hausen
Journal:  Virology       Date:  1991-09       Impact factor: 3.616

9.  Genome amplification of human papillomavirus types 16 and 18 in cervical carcinomas is related to the retention of E1/E2 genes.

Authors:  J Berumen; L Casas; E Segura; J L Amezcua; A Garcia-Carranca
Journal:  Int J Cancer       Date:  1994-03-01       Impact factor: 7.396

10.  Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.

Authors:  C Yee; I Krishnan-Hewlett; C C Baker; R Schlegel; P M Howley
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307
View more
  6 in total

1.  Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity.

Authors:  Helen Trottier; Silvaneide Ferreira; Patricia Thomann; Maria C Costa; Joao S Sobrinho; José Carlos M Prado; Thomas E Rohan; Luisa L Villa; Eduardo L Franco
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

2.  Modulation of Alternaria infectoria cell wall chitin and glucan synthesis by cell wall synthase inhibitors.

Authors:  Chantal Fernandes; Jorge Anjos; Louise A Walker; Branca M A Silva; Luísa Cortes; Marta Mota; Carol A Munro; Neil A R Gow; Teresa Gonçalves
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

3.  Comparative study of different standardization concepts in quantitative competitive reverse transcription-PCR assays.

Authors:  G Haberhausen; J Pinsl; C C Kuhn; C Markert-Hahn
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

4.  Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.

Authors:  Andrea Trevisan; João M G Candeias; Patrícia Thomann; Luisa L Villa; Eduardo L Franco; Helen Trottier
Journal:  J Med Microbiol       Date:  2020-07       Impact factor: 2.472

5.  A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings.

Authors:  M V Jacobs; J M Walboomers; J van Beek; F J Voorhorst; R H Verheijen; C J Meijer; A J van den Brule; T J Helmerhorst; P J Snijders
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

6.  Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.

Authors:  D T Geraets; K Cuschieri; M N C de Koning; L J van Doorn; P J F Snijders; C J L M Meijer; W G V Quint; M Arbyn
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.